Science Explorer Interactive view Map
Company · Espoo · Finland

Glaxosmithkline (Finland)

fi.gsk.comROR OpenAlex
Research works
56
▲ 207% vs 2013–17
Citations
1.3k
23.3 per fractional work
Top-10% rate
22.8%
record average 16.5%
Open access
52%
world 28%

Not ranked overall: Glaxosmithkline (Finland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.01× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.20× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 6.16× its world share, 1 worksImmunology and Micro…Neuroscience: 0.34× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.59× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.63× its world share, 0 worksChemistryComputer Science: 0.07× its world share, 0 worksComputer ScienceEarth and Planetary Sciences: 0.91× its world share, 0 worksEarth and Planetary …Engineering: 0.45× its world share, 2 worksEngineeringEnvironmental Science: 0.15× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.24× its world share, 0 worksMaterials ScienceMathematics: 1.82× its world share, 0 worksMathematicsHealth Professions: 0.99× its world share, 1 worksHealth ProfessionsMedicine: 3.34× its world share, 15 worksMedicineNursing: 0.42× its world share, 0 worksNursingDecision Sciences: 0.33× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.19× its world share, 1 worksEconomics, Econometr…Psychology: 0.11× its world share, 0 worksPsychologySocial Sciences: 0.21× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.2×. Every wedge is a field page.

Which keywords describe research at Glaxosmithkline (Finland)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Treatment, Inflammation, Asthma, Genetics, Immunology, Allergic Diseases and Eosinophils.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 13 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 13 words, with their numbers
  1. Epidemiology5▲ 5.7×24 topics
  2. Inflammation3▲ 6.0×14 topics
  3. Treatment3▲ 9.8×6 topics
  4. Asthma2▲ 99×2 topics
  5. Genetics2▲ 13×2 topics
  6. Immunology2▲ 83×2 topics
  7. Allergic Diseases2▲ 140×1 topic
  8. Eosinophils2▲ 140×1 topic
  9. Management2▲ 8.3×8 topics
  10. Diagnosis1▲ 6.5×7 topics
  11. Quality of Life1▲ 3.9×11 topics
  12. Antimicrobial Resistance1▲ 23×4 topics
  13. Treatment Guidelines1▲ 20×2 topics

Which research topics does Glaxosmithkline (Finland) publish most on?

By volume in 2022–2025: Asthma and respiratory diseases, Urinary Tract Infections Management, Respiratory and Cough-Related Research and Reproductive tract infections research.

Asthma and respiratory d…2Asthma and respiratory diseases: 2 fractional worksUrinary Tract Infections Management: 1 fractional worksRespiratory and Cough-Re…1Respiratory and Cough-Related Research: 1 fractional worksReproductive tract infec…1Reproductive tract infections research: 1 fractional worksInhalation and Respiratory Drug Delivery: 1 fractional worksSystemic Lupus Erythematosus Research: 0 fractional worksChronic Obstructive Pulm…0Chronic Obstructive Pulmonary Disease (COPD) Research: 0 fractional worksPediatric Urology and Ne…0Pediatric Urology and Nephrology Studies: 0 fractional worksEosinophilic Disorders a…0Eosinophilic Disorders and Syndromes: 0 fractional worksOvarian cancer diagnosis…0Ovarian cancer diagnosis and treatment: 0 fractional works
PhysiologyEpidemiologyPulmonary and Respiratory MedicineMicrobiology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Asthma and respiratory diseases Physiology 2 works
  2. 2 Urinary Tract Infections Management Epidemiology 1 works
  3. 3 Respiratory and Cough-Related Research Pulmonary and Respiratory Medicine 1 works
  4. 4 Reproductive tract infections research Microbiology 1 works
  5. 5 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 1 works
  6. 6 Systemic Lupus Erythematosus Research Rheumatology 0 works
  7. 7 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 0 works
  8. 8 Pediatric Urology and Nephrology Studies Pediatrics, Perinatology and Child Health 0 works
  9. 9 Eosinophilic Disorders and Syndromes Rheumatology 0 works
  10. 10 Ovarian cancer diagnosis and treatment Reproductive Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available52.5%not open47.5%

World: 28% of research is openly available.

with international co-authors84.5%domestic only15.5%

World: 19% is written across borders.

How has Glaxosmithkline (Finland)'s research output changed?

Output in 2018–2022 was 207% higher than in 2013–2017.

199520002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Espoo

All research institutions in Espoo

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.